Alpha Tau Medical Ltd. - דינמיקת הכנסות משנה לשנה ב-12 החודשים האחרונים DRTS

The year-over-year percentage change in sales volume for LTM reflects the adoption dynamics of alpha therapy for solid tumors, where consumable shipments serve as a steady cash cow. This innovative radiation delivery method enables Alpha Tau Medical Ltd. (DRTS) to maintain significant pricing power. Growing global demand for targeted treatment in advanced stages of cancer confirms the expansion potential, while the 0.00 indicator determines the magnitude of the metric.
פילוחי נתונים אנליטיים מרוכזים עבור Alpha Tau Corp (DRTS)

Alpha Tau Medical Ltd. (DRTS) development of universal alpha-therapy methods to combat solid tumors requires a steady influx of resources to diversify clinical trials. By analyzing the year-over-year sales trend over a 12-month period, an investor assesses the percentage growth of rolling annual revenue, which smooths out volatility and determines the actual speed of operational dynamics for this high-risk security.